Работы, цитирующие эту работу

Работ: 2

Работа: Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial

1. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

   Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5

   СтатьяCAR-T cell therapy researchJournal of Hematology & Oncology2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.article.000083

2. Interactions and communications in the glioblastoma microenvironment: potential targets for chemo-/radiotherapy

   Qamar Abuhassan, Hamzeh Al-Ameer, Subbulakshmi Ganesan +5

   СтатьяGlioma Diagnosis and TreatmentStrahlentherapie und Onkologie2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.013344